ImmunityBio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2014 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ImmunityBio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2014 to Q4 2023.
  • ImmunityBio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $648M, a 31.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $648M +$157M +31.9% Dec 31, 2023 10-K 2024-03-19
Q4 2022 $492M +$117M +31.1% Dec 31, 2022 10-K 2024-03-19
Q4 2021 $375M +$114M +43.5% Dec 31, 2021 10-K 2023-03-01
Q4 2020 $261M +$63.4M +32% Dec 31, 2020 10-K 2022-03-01
Q4 2019 $198M +$53.3M +36.8% Dec 31, 2019 8-K/A 2021-04-22
Q4 2018 $145M +$25.8M +21.6% Dec 31, 2018 10-K 2020-03-25
Q4 2017 $119M -$8.32M -6.53% Dec 31, 2017 10-K 2019-03-13
Q4 2016 $127M +$58.2M +84.2% Dec 31, 2016 10-K 2018-03-12
Q4 2015 $69.1M -$92.9M -57.3% Dec 31, 2015 10-K 2017-03-15
Q4 2014 $162M Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.